Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Neurocrine Bioscienc (NBIX)
Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neurocrine Bioscienc 12780 EL CAMINO REAL SAN DIEGO CA 92130 USA

P: 858-617-7600

Description:

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.

Key Statistics

Overview:

Market Capitalization, $K 10,985,850
Enterprise Value, $K 10,722,950
Shares Outstanding, K 97,652
Annual Sales, $ 1,489 M
Annual Net Income, $ 154,500 K
Last Quarter Sales, $ 452,700 K
Last Quarter Net Income, $ 95,500 K
EBIT, $ 150,600 K
EBITDA, $ 167,400 K
60-Month Beta 0.46
% of Insider Shareholders 4.40%
% of Institutional Shareholders 93.54%
Float, K 93,355
% Float 95.60%
Short Volume Ratio 0.53

Growth:

1-Year Return 9.48%
3-Year Return 18.92%
5-Year Return -2.64%
5-Year Revenue Growth 821.05%
5-Year Earnings Growth 196.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.95 on 08/01/23
Next Earnings Date 11/07/23
Earnings Per Share ttm 1.73
EPS Growth vs. Prev Qtr 220.25%
EPS Growth vs. Prev Year 627.78%
Annual Dividend Yield 0.00%
Dividend Payable Date 12/31/69
Dividend Payout Ratio 0.00%

NBIX Ratios

Ratio
Price/Earnings ttm 66.57
Price/Earnings forward 52.37
Price/Earnings to Growth 1.14
Return-on-Equity % 10.39%
Return-on-Assets % 7.44%
Profit Margin % 10.38
Net Margin % 20.23
Debt/Equity 0.10
Price/Sales 7.55
Price/Cash Flow 64.63
Price/Book 6.07
Book Value/Share 18.98
Interest Coverage 31.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar